Hemophilia gene therapy is heralding a new era in the treatment of this inherited bleeding disorder, offering patients hope for a life free from constant medical interventions.With the recent FDA approval of Hemgenix, a groundbreaking gene therapy specifically for hemophilia B, patients like Terence Blue are experiencing significant relief from the daily challenges of maintaining adequate levels of clotting factor IX.